New stability indicating RP-HPLC-PDA method for determination of mifepristone in bulk and tablet formulation
Abstract Background Mifepristone is progestational and glucocorticoid hormone antagonist. The objective of this study is to develop simple and economical stability indicating RP-HPLC method for the determination of mifepristone in bulk and tablet formulation. Result The chromatographic separation wa...
Guardado en:
Autores principales: | Mohammad Mojeeb Gulzar Khan, Mohammad Faizan Saadique Deshmukh, Sandip Dinkar Firke, Abdul Talib Abdul Wahab, Mohan Ganpatrao Kalaskar, Atul Arun Shirkhedkar |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
SpringerOpen
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/95aae83e816140e39d43cd909b62b8d0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Mifepristone Directly Disrupts Mouse Embryonic Development in Terms of Cellular Proliferation and Maturation In Vitro
por: Yu-Ting Su, et al.
Publicado: (2021) -
STABILITY-INDICATING RP-HPLC METHOD FOR ANALYSIS OF ATORVASTATIN IN BULK DRUG, MARKETED TABLET AND NANOEMULSION FORMULATION
por: MUSTAFA,GULAM, et al.
Publicado: (2010) -
Computational repositioning and preclinical validation of mifepristone for human vestibular schwannoma
por: Jessica E. Sagers, et al.
Publicado: (2018) -
Anticancer effects of mifepristone on human uveal melanoma cells
por: Prisca Bustamante Alvarez, et al.
Publicado: (2021) -
SIMULTANEOUS ESTIMATION OF MOXIFLOXACIN HYDROCHLORIDE AND DEXAMETHASONE SODIUM PHOSPHATE IN BULK AND IN OPHTHALMIC SOLUTION BY RP- HPLC
por: DHUMAL,D. M, et al.
Publicado: (2012)